# Gaston J H Franssen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gaston-j-h-franssen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,029 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 23 |
| i10-index | 34 |
| Last Known Institution | Erasmus MC Cancer Institute |
| OpenAlex ID | https://openalex.org/A5103121336 |
| ORCID iD | 0000-0002-4730-9019 |
| Works | 60 |

## Researcher papers

- [Long-Term Efficacy, Survival, and Safety of \[177Lu-DOTA0,Tyr3\]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors](https://scholariq.org/papers/long-term-efficacy-survival-and-safety-of-177lu-dota0-tyr3-octreotate-in/)
- [Subacute haematotoxicity after PRRT with 177Lu-DOTA-octreotate: prognostic factors, incidence and course](https://scholariq.org/papers/subacute-haematotoxicity-after-prrt-with-177lu-dota-octreotate-prognostic/)
- [Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors](https://scholariq.org/papers/prevalence-and-clinical-features-of-the-ectopic-acth-syndrome-in-patients-with/)
- [Systematic review of surgical and medical treatment for tertiary hyperparathyroidism](https://scholariq.org/papers/systematic-review-of-surgical-and-medical-treatment-for-tertiary/)
- [Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE](https://scholariq.org/papers/treatment-of-inoperable-or-metastatic-paragangliomas-and-pheochromocytomas-with/)
- [Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study](https://scholariq.org/papers/osilodrostat-is-a-potential-novel-steroidogenesis-inhibitor-for-the-treatment-of/)
- [ENDOCRINOLOGY IN PREGNANCY: Pheochromocytoma in pregnancy: case series and review of literature](https://scholariq.org/papers/endocrinology-in-pregnancy-pheochromocytoma-in-pregnancy-case-series-and-review/)
- [Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis](https://scholariq.org/papers/complex-max-rearrangement-in-a-family-with-malignant-pheochromocytoma-renal/)
- [Future directions in the diagnosis and medical treatment of adrenocortical carcinoma](https://scholariq.org/papers/future-directions-in-the-diagnosis-and-medical-treatment-of-adrenocortical/)
- [Mefloquine and an Acute Brain Syndrome](https://scholariq.org/papers/mefloquine-and-an-acute-brain-syndrome/)
- [Radiofrequency Ablation for Benign Symptomatic Thyroid Nodules in the Netherlands: Successful Introduction of a Minimally Invasive Treatment Option Improving Quality of Life](https://scholariq.org/papers/radiofrequency-ablation-for-benign-symptomatic-thyroid-nodules-in-the/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Adrenal and Paraganglionic Tumors](https://scholariq.org/topics/adrenal-and-paraganglionic-tumors/)
- [Pituitary Gland Disorders and Treatments](https://scholariq.org/topics/pituitary-gland-disorders-and-treatments/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

## Researcher university

- [Erasmus MC Cancer Institute](https://scholariq.org/institutions/erasmus-mc-cancer-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.